FROM THE CANSWER FORUM what’s in store for 2018

Corry

Marketing Manager

What’s in store for 2018?

 

  • AJCC 8th Edition Chapter Updates to Histologies  (Release by June 15, 2017)

Responsible organization: AJCC (Lead: Laura Meyer)

      • Need to verify histologies for each AJCC chapter. There is currently a collaborative effort that includes AJCC (Lead: Laura Meyer), NCI SEER (Lead: Serban Negoita), and CDC NPCR (Lead: Lori Pollock) that is developing new recommendations on eligible histology types for each chapter.
        • Comparison of AJCC 8th Edition versus WHO Classification Monographs versus ICD-O-3 has been completed for all but 2 classifications released by WHO
        • CDC, NCI and CoC presented “Eligibility of staging by histologic codes and terms in AJCC 8th edition:  Issues and recommendations from national cancer surveillance systems” at the AJCC Executive Meeting (April 24th, 2017)
        • AJCC experts (Dr. K Washington, Ms. D. Gress) reviewed histology codes included and the above-listed document, agreed that certain additional histology codes need to be added to eligibility list.
        • Final decision deferred to AJCC Manual chapter authors.
        • All surveillance partners, including AJCC, agreed that if histology code is eligible then both in-situ and invasive behaviors associated with the histology will become eligible for AJCC staging.
        • The completion of this work will impact the release of a TNM DLL and the programing of abstraction tool updates for cancer reporters.
        • The completion of this work will impact the EDITS timeline.
  • ICD-O-3 Histology Revisions (Release by August 1, 2017)

Responsible organization: NAACCR ICD-O-3 Implementation Guidelines Work Group (Lead: Lois Dickie (NCI SEER)) NAACCR staff: Jim Hofferkamp

      • This WG is identifying new terms used for current codes, new codes, and codes with changes in behavior that will be used in 2018.
        • Changes that impact reportability should be finalized by July 1, 2017.
        • All changes should be finalized by August 1, 2017.
      • SEER has contract workers reviewing the most current WHO blue books and comparing their findings with current ICD-O-3 codes and terms –  work completed for all available WHO book 4th edition (including WHO Classification Head and Neck Tumours published in February 2018))  
      • SEER Update site/histology validation list (Release November 1, 2017)
  • New and Revised Stage Data Items (Submit to UDS by August 1, 2017)

Responsible organization: NAACCR Site Specific Data Items Work Group (Lead: Jennifer Ruhl (NCI SEER) and Elizabeth Ward (NAACCR Contract)) NAACCR staff: Jim Hofferkamp and Lori Havener

      • Finalize New Site-Specific Data Items (Submit to UDS by August 1, 2017)
        • New data items required for AJCC 8 stage calculation (May 15, 2017)
        • New data items not required for stage proposed for collection in 2018 (Submit to UDS by August 1, 2017)
      • Existing site-specific data items for which changes are proposed (Submit to UDS by August 1, 2017)
      • Update stage data items. Allowable values updated to reflect AJCC 8th Edition, values and labels reconciled, and length of data items expanded. (Submit to UDS by June 15, 2017)
        • Clin T, Clin N, Clin M
        • Clinical Stage
        • Path T, Path N, Path M
        • Pathologic Stage
        • ypath T, ypath N, ypath M
        • Post neoadjuvant therapy stage
        • AJCC Grade Post neoadjuvant therapy
        • Stage Suffixes: Clin T Suffix, Clin N Suffix, Path T Suffix, Path N Suffix, ypath T Suffix, ypath N Suffix
  • MP/H Rules (Release by October 1, 2017)

Responsible organization: NCI SEER (Lead: Lois Dickie (NCI SEER)) NAACCR staff: Jim Hofferkamp and Angela Martin

      • New rules for determining multiple primaries and histologies.
      • New name “solid tumor manual”.
      • Draft completed, available for Committee review for 4 schemas.
  • SEER Summary Stage 2018 and SEER EOD 2018 (Release by November 1, 2017)

Responsible organization: NCI SEER (Lead: Jennifer Ruhl (NCI SEER))

      • Designed to reflect changes in the AJCC 8th Edition.
      • SEER Summary Stage 2018 will be derived from SEER EOD 2018.
      • Directly assigned Summary Stage 2018 will be available for registries that do not collect SEER EOD 2018.
      • EOD testing activity to be conducted June-July, 2018; volunteer participants will have early access to certain EOD data items and coding instructions, and will provide access to instructions clarity and technical accuracy.
  • Standards Volume II, Version 18 (Release December 1, 2017)

Responsible organization: NAACCR Uniform Data Standards Work Group (Leads: Cheryl Moody (California Cancer Registry) and Suzanne Schwartz (New Jersey State Cancer Registry)) NAACCR Staff: Lori Havener

      • New/Changed Data Items – a list of all new and changed data items will be provided. (Finalize by September 1, 2017)
      • New Record Layout (Finalize by October 1, 2017)
        • A new record layout will be developed due to the large number of new data items added for 2018. The record layout cannot be developed until all of the new data items have been finalized.
      • Standard Setter Requirements – Volume II, Chapter 8 (Finalize by October 1, 2017)
  • CoC 2018 STORE Manual (Release by January 2018) (Replacing FORDS)

Responsible organization: CoC NCDB (Lead: Kathleen K Thoburn, CoC)

      • Designed to reflect changes in the AJCC 8th Edition.
      • Updated to reflect new non-staging related data items.
      • New manual format
  • EDITS/TNM Edits (Release EDITS metafile January 1, 2018)

Responsible organization: NAACCR EDITS Work Group (Lead: Jim Hofferkamp (NAACCR))

      • Edits will have to be developed for all new data items. At a minimum all new data items will require valid value edits.
      • Edits and edit related tables will have to be updated to accommodate changes to chapter site/histologies and new values in AJCC 8th Edition.
      • Edits and edit related tables will have to be updated to accommodate new histologies and changes to histology coding rules coming out of ICD-O-3 Implementation WG.
      • Current TNM Edits will be reviewed to see if they can be adapted to AJCC 8th Edition.
      • Edits comparing T, N, M, and stage values with new SSDIs.
      • Implementation of EditWriter 5.
  • 2018 Implementation Guidelines (Release by February 1, 2018)

Responsible organization: NAACCR Implementation Guidelines Task Force (Lead: TBD) NAACCR Staff: Lori Havener

      • The release of the 2018 Implementation Guidelines and Recommendations is dependent on the timely release of all 2018 components listed above.
  • Other Activities for 2018:
    • Cancer Registry Software Development
      • CDC NPCR TNM DLL
      • NCI SEER RSA
      • Hospital and central cancer registry software updates.
    • Central Registry Modifications to Manuals
      • Central registries will need time to modify their consolidation process to accommodate new MP/H rules.
    • Education and Training